| Literature DB >> 32475004 |
Helgi K Björnsson1, Einar S Björnsson1, Bharathi Avula2, Ikhlas A Khan2, Jon G Jonasson1, Marwan Ghabril3, Paul H Hayashi4, Victor Navarro5.
Abstract
In a recent letter to the editor, by Mohan et al. 1 , the authors make comments on our recently published paper "Liver Injury due to Ashwagandha . A Case Series from Iceland and the US Drug-Induced Liver Injury Network"2 . The authors do not agree with the conclusions of the paper regarding the hepatotoxic potential of ashwagandha.2 In the paper, five cases of suspected liver injury after consumption of ashwagandha-containing herbal supplements were described. This article is protected by copyright. All rights reserved.Entities:
Year: 2020 PMID: 32475004 DOI: 10.1111/liv.14551
Source DB: PubMed Journal: Liver Int ISSN: 1478-3223 Impact factor: 5.828